Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accounts-Payable" stands at 9.62 Billion United States Dollars as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Accounts Payable" stands at 9.62 Billion USD. This represents an increase of 1.70 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.49 percent compared to the value the year prior.
The 1 year change in percent is 7.49.
The 3 year change in percent is -5.20.
The 5 year change in percent is 36.64.
The 10 year change in percent is 114.56.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |
![]() | Novartis AG - Accounts Payable | 255,096,620,580.91 |